JHS Svendgaard Labs adopts FY26 financials at 22nd AGM
- JHS Svendgaard Laboratories held its 22nd AGM on September 26, 2026, via video conferencing
- Members adopted audited standalone and consolidated financial statements for FY26
- Paramvir Singh appointed as director liable to retire by rotation
- 88 members participated in the meeting, which concluded at 3:49 pm

*this image is generated using AI for illustrative purposes only.
JHS Svendgaard Laboratories Limited held its 22nd Annual General Meeting on September 26, 2026. The meeting was conducted through Video Conferencing and Other Audio-Visual Means in compliance with regulatory guidelines.
Members adopted the audited standalone and consolidated financial statements for the financial year ended March 31, 2026. The Board of Directors' reports and auditors' reports were also taken as read, with no qualifications noted for the period.
Key resolutions passed
The shareholders transacted ordinary business items as outlined in the notice dated September 2, 2026. The following resolutions were considered:
| Item | Resolution Description | Type |
|---|---|---|
| 1 | Adopt audited standalone financial statements for FY26 | Ordinary |
| 2 | Adopt audited consolidated financial statements for FY26 | Ordinary |
| 3 | Appoint Paramvir Singh as director liable to retire by rotation | Ordinary |
Meeting proceedings and attendance
The meeting commenced at 3:00 pm and concluded at 3:49 pm, including time allocated for e-voting. A total of 88 members participated in the session. The following directors and key managerial personnel attended:
- R.C. Venkateish: Chairperson & Independent Director
- Nikhil Nanda: Managing Director
- Paramvir Singh: Director & CEO
- Kapil Minocha: Independent Director
- Vinay Mittal: Non-Executive Director
- Upma Chawdhry: Independent Director
- Ashish Goel: Chief Financial Officer
- Komal Jha: Company Secretary and Compliance Officer
The Statutory Auditors, represented by Divya Khosla from V.K Khosla & Co., and the Secretarial Auditors, Mohit Dahiya from Dahiya & Associates, were present virtually. The scrutinizer oversaw the e-voting process facilitated by NSDL.
Governance and compliance
The Chairman addressed the members regarding the company's performance and future outlook during the financial year under review. The Managing Director shared insights on business achievements and growth initiatives. The audit, stakeholder relationship, and nomination committees were represented by their respective chairpersons.
The consolidated voting results will be published on the company's website and filed with the stock exchanges. The meeting adhered to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and relevant Ministry of Corporate Affairs circulars.
Historical Stock Returns for JHS Svendgaard Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.06% | -1.86% | -6.44% | +17.41% | -24.19% | -65.66% |
How will the appointment of Paramvir Singh as Director and CEO influence JHS Svendgaard's strategic direction for the upcoming fiscal year?
What specific growth initiatives did the Managing Director highlight that are expected to drive revenue expansion in FY27?
How does the clean audit opinion for FY26 position the company for potential capital raises or debt restructuring in the near term?


































